An Australian pharmaceutical company confirmed Wednesday that it has entered preliminary talks about potentially purchasing the well-known British pharmacy chain Boots, addressing recent media reports about the possible acquisition.
Sigma Healthcare, which operates as both a pharmaceutical distributor and retailer, acknowledged the early-stage discussions while emphasizing that the company regularly evaluates potential opportunities that might benefit shareholders. However, the company stressed that there is no guarantee any deal will ultimately come to fruition.
